Your session is about to expire
← Back to Search
FallsTalk-C for Falls (FT-C Trial)
N/A
Waitlist Available
Led By Victoria Panzer, PhD
Research Sponsored by Brookside Research & Development Company
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly for up to one year
Awards & highlights
FT-C Trial Summary
This study is evaluating whether a new intervention may help reduce the number of falls for individuals with memory loss or dementia.
FT-C Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weekly for up to one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly for up to one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change of Residence
Rate of falls
Secondary outcome measures
Activity-Specific Balance Confidence scale
Burden Scale for Family Caregivers
Caregiver Falls Prevention Concerns
+1 moreFT-C Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: FallsTalk-CExperimental Treatment2 Interventions
FallsTalk CG intervention
Group II: FallsTalkActive Control1 Intervention
FallsTalk intervention
Group III: PostCardOnlyActive Control1 Intervention
Postcard only- Control group
Find a Location
Who is running the clinical trial?
Brookside Research & Development CompanyLead Sponsor
National Institute on Aging (NIA)NIH
1,662 Previous Clinical Trials
28,004,514 Total Patients Enrolled
Alzheimer's AssociationOTHER
89 Previous Clinical Trials
40,663 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger